SCHEMBL30852253

SCHEMBL30852253

CCOC(=O)CC1CC=C(c2cnsc2C)CC1

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CCNT1 O60563 4/20 0.34
CDK9 P50750 4/20 0.34
NPC1 O15118 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TSHR P16473 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
CYP1A2 P05177 1/20 0.32
IDO1 P14902 1/20 0.31
CYP11B1 P15538 3/20 0.31
CYP11B2 P19099 3/20 0.31
JAK2 O60674 1/20 0.31
JAK1 P23458 1/20 0.31
TYK2 P29597 1/20 0.31
JAK3 P52333 1/20 0.31
PDE5A O76074 1/20 0.30
HDAC1 Q13547 1/20 0.30
HDAC6 Q9UBN7 1/20 0.30
MIF P14174 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17731129 0.77 CYP11B1 (0.33) CCNT1CDK9NPC1ALDH1A1TSHR
SCHEMBL30851813 0.77 CCNT1 (0.34) CCNT1CDK9NPC1ALDH1A1TSHR
SCHEMBL30852138 0.75 KDM4E (0.40) CCNT1CDK9NPC1ALDH1A1TSHR
SCHEMBL17318345 0.74 ALDH1A1 (0.37) CCNT1CDK9ALDH1A1RAB9AJAK2
SCHEMBL30851928 0.74 CCNT1 (0.34) CCNT1CDK9NPC1ALDH1A1TSHR
SCHEMBL19899836 0.74 CDK9 (0.45) CCNT1CDK9CYP11B1CYP11B2JAK2
SCHEMBL30852194 0.74 CDK9 (0.38) CCNT1CDK9RAB9AIDO1CYP11B1
SCHEMBL15182066 0.74 SMN1; SMN2 (0.49) NPC1ALDH1A1TSHRRAB9ASMN1; SMN2
SCHEMBL30852068 0.73 CYP11B1 (0.41) CCNT1CDK9RAB9AIDO1CYP11B1
SCHEMBL25270376 0.73 ESR2 (0.43) NPC1ALDH1A1RAB9ASMN1; SMN2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4587014-A2 C5AR1 ANTAGONISTS AND USES THEREOF Vanqua Bio, Inc. (US) 2025-07-23 EP disclosed
WO-2024059096-A2 C5AR1 ANTAGONISTS AND USES THEREOF VANQUA BIO, INC. (US) 2024-03-21 WO disclosed